EBS
Emergent BioSolu (EBS)
NYSE
$6.15-$0.09 (-1.36%)
Price as of Sep 11, 2026 7:59 PM EDT
  • $319.4M
    Market Cap
  • -23.46%
    1-Year Change
  • Drug Manufacturers - Specialty & Generic
    Industry

Earnings Score

Score: 40
Valuation
EBS
vs History
vs S&P 500
Profitability
-1
Growth
-1
Low Earnings Volatility
0

Momentum Score

Score: 37
Valuation
EBS
vs History
vs S&P 500
3-Month Momentum
-42.77%
12-Month Momentum
-44.71%
3-Month Risk Adjusted Momentum
-118.23%
12-Month Risk Adjusted Momentum
-58.68%

True Yield

N/A
Valuation
EBS
vs History
vs S&P 500
Dividend Yield
N/A
Net Buyback Yield
6.08%
Net Debt Paydown Yield
-1.68%

Financial Health Score

Score: 28
Valuation
EBS
vs History
vs S&P 500
Ohlson's O-Score
4